Copegus (Ribavirin) - Disability - Suspected Cause - Side Effect Reports

Possible Copegus side effects in female

Reported by a physician from Israel on 2012-08-13

Patient: female

Reactions: Neuropathy Peripheral, Cryoglobulinaemia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Pegasys
    Dosage: date of last dose prior to sae: 20/feb/2012
    Indication: Hepatitis C
    Start date: 2011-03-27
    End date: 2012-02-20

Copegus
    Dosage: date of last dose prior to sae: 20/feb/2012
    Indication: Hepatitis C
    Start date: 2011-03-27
    End date: 2012-02-20

Other drugs received by patient: Levothyroxine Sodium; Betacorten; Brimonidine Tartrate

Possible Copegus side effects in

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-10

Patient:

Reactions: Bronchitis Bacterial, Anaemia, Pancytopenia, Myocardial Infarction, Acute Myocardial Infarction

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Copegus
    Dosage: 400-800 mg
    Administration route: Oral

Pegasys

Victrelis
    Administration route: Oral

Other drugs received by patient: Doxycycline HCL

Possible Copegus side effects in male

Reported by a physician from United States on 2012-08-02

Patient: male, weighing 67.0 kg (147.4 pounds)

Reactions: Pericarditis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Dosage: reduced dosage
    Start date: 2012-03-20
    End date: 2012-05-28

Pegasys
    Start date: 2012-05-28

Pegasys
    Dosage: reduced dosage
    Start date: 2012-02-06
    End date: 2012-03-20

Copegus
    Indication: Hepatitis C
    Start date: 2011-07-08

RO 5466731 (Hcv Ns5b Inhibitor)
    Dosage: loading dose
    Indication: Hepatitis C
    Start date: 2011-07-08
    End date: 2012-06-04

Pegasys
    Indication: Hepatitis C
    Start date: 2011-07-08
    End date: 2012-02-06

Copegus
    Start date: 2012-06-04

Possible Copegus side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01

Patient:

Reactions: Polyneuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Copegus
    Dosage: 1000 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01
    End date: 2012-03-14

Pegasys
    Dosage: 130 microgram, unk
    Indication: Hepatitis C
    Start date: 2012-01-01
    End date: 2012-03-14

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-29
    End date: 2012-03-14

Possible Copegus side effects in male

Reported by a physician from France on 2012-07-27

Patient: male

Reactions: Polyneuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    Start date: 2012-01-01
    End date: 2012-03-14

Pegasys
    Start date: 2012-01-01
    End date: 2012-03-14

Pegasys
    Indication: Product Used FOR Unknown Indication

Copegus
    Indication: Product Used FOR Unknown Indication

Victrelis
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-29
    End date: 2012-03-14

Possible Copegus side effects in female

Reported by a physician from United States on 2012-07-27

Patient: female, weighing 64.5 kg (141.9 pounds)

Reactions: Emotional Distress

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-06-07
    End date: 2011-08-24

Blinded RO 5466731 (Hcv Ns5b Inhibitor)
    Indication: Hepatitis C
    Start date: 2011-06-07
    End date: 2011-08-24

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-06-07
    End date: 2011-08-24

Other drugs received by patient: Vitamin D; Advil; Nexium; Lamotrigine

Possible Copegus side effects in male

Reported by a physician from Germany on 2012-07-19

Patient: male, weighing 73.0 kg (160.6 pounds)

Reactions: Germ Cell Cancer

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-10-19
    End date: 2012-03-03

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-03

Other drugs received by patient: Methadone HCL

Possible Copegus side effects in male

Reported by a physician from United States on 2012-07-05

Patient: male, weighing 67.0 kg (147.4 pounds)

Reactions: Pericarditis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-07-08
    End date: 2012-02-06

RO 5466731 (Hcv Ns5b Inhibitor)
    Dosage: loading dose
    Indication: Hepatitis C
    Start date: 2011-07-08
    End date: 2012-06-04

Pegasys
    Dosage: reduced dosage
    Start date: 2012-02-06
    End date: 2012-05-28

Copegus
    Indication: Hepatitis C
    Start date: 2011-07-08

Pegasys
    Start date: 2012-05-28

Copegus
    Start date: 2012-06-04

Possible Copegus side effects in 65 year old male

Reported by a physician from Germany on 2012-06-26

Patient: 65 year old male, weighing 108.0 kg (237.6 pounds)

Reactions: Atrial Septal Defect, Hemianopia, Cerebrovascular Accident

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Victrelis
    Dosage: po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-14

Copegus
    Dosage: po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-03-29

Peginterferon Alfa-2A
    Dosage: 180 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2011-03-29

Possible Copegus side effects in male

Reported by a physician from Germany on 2012-06-25

Patient: male, weighing 82.0 kg (180.4 pounds)

Reactions: Retinal Vein Occlusion, Macular Oedema

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Copegus
    Indication: Hepatitis C
    Start date: 2011-09-29

Boceprevir
    Indication: Hepatitis C

Pegasys
    Indication: Hepatitis C
    Start date: 2011-09-29

Possible Copegus side effects in 50 year old male

Reported by a consumer/non-health professional from Germany on 2012-06-11

Patient: 50 year old male, weighing 84.0 kg (184.8 pounds)

Reactions: Bronchitis Bacterial, Anaemia, Pancytopenia, Myocardial Infarction, Acute Myocardial Infarction

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-14
    End date: 2012-03-26

Boceprevir
    Start date: 2012-02-14
    End date: 2012-03-26

Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-14
    End date: 2012-03-21

Copegus
    Dosage: 400-800 mg
    Start date: 2012-01-14
    End date: 2012-03-26

Boceprevir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-14
    End date: 2012-03-26

Other drugs received by patient: Doxycycline

Possible Copegus side effects in female

Reported by a individual with unspecified qualification from United States on 2012-06-07

Patient: female, weighing 84.5 kg (185.9 pounds)

Reactions: B-Cell Lymphoma Stage IV, Pneumonia, Pulmonary Vasculitis, Pancytopenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-04-27

Copegus
    Start date: 2011-07-05
    End date: 2011-07-05

Copegus
    Administration route: Oral
    Start date: 2011-04-27
    End date: 2011-05-10

RO 5466731 (Hcv Ns5b Inhibitor)
    Dosage: date of dicontinuation: 05/jul/2011
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-07-05

Pegasys
    Start date: 2011-04-20
    End date: 2011-06-29

Pegasys
    Start date: 2011-06-29

Copegus
    Start date: 2011-07-05

Pegasys
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-04-20

Pegasys
    Start date: 2011-06-29
    End date: 2011-06-29

Copegus
    Administration route: Oral
    Start date: 2011-05-10
    End date: 2011-07-05

Other drugs received by patient: Spironolactone; Lasix; RED Cells Pack; Lortab; Lasix; Rabeprazole Sodium; Alprazolam; Diphenhydramine HCL; Protonix; Lithium Carbonate; Promethazine; Zolpidem; Epoetin Alfa; Acetaminophen

Possible Copegus side effects in female

Reported by a physician from United States on 2012-05-18

Patient: female, weighing 93.9 kg (206.5 pounds)

Reactions: Intraventricular Haemorrhage, Subarachnoid Haemorrhage, Aneurysm, Concomitant Disease Progression, Femoral Artery Aneurysm

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Copegus
    Dosage: 3 dosage form
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-20
    End date: 2012-01-29

Blinded Alisporivir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-20
    End date: 2012-01-29

Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-20
    End date: 2012-01-27

Other drugs received by patient: Acetaminophen; Ascorbic Acid; Naproxen; Lisinopril; Clonazepam; Calcium

Possible Copegus side effects in male

Reported by a physician from United Kingdom on 2012-05-09

Patient: male, weighing 81.0 kg (178.2 pounds)

Reactions: Enterovesical Fistula, Diarrhoea, Diverticulitis, Gastroenteritis, Rash, Pyrexia, Hyperhidrosis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-10

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10

BI 201335 (Hcv Protease Inhibitor)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10

Other drugs received by patient: Pandol; Acetaminophen

Possible Copegus side effects in male

Reported by a physician from United Kingdom on 2012-05-02

Patient: male, weighing 91.0 kg (200.2 pounds)

Reactions: Enterovesical Fistula, Diarrhoea, Diverticulitis, Rash, Hyperhidrosis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-10

BI 201335 (Hcv Protease Inhibitor)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10

Other drugs received by patient: Pandol; Acetaminophen

Possible Copegus side effects in female

Reported by a physician from Israel on 2012-05-01

Patient: female

Reactions: Cryoglobulinaemia, Vasculitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Pegasys
    Dosage: date of last dose prior to sae: 20/feb/2012
    Indication: Hepatitis C
    Start date: 2011-03-27
    End date: 2012-02-20

Copegus
    Dosage: date of last dose prior to sae: 20/feb/2012
    Indication: Hepatitis C
    Start date: 2011-03-27
    End date: 2012-02-20

Possible Copegus side effects in female

Reported by a physician from Canada on 2012-04-09

Patient: female, weighing 78.5 kg (172.7 pounds)

Reactions: Renal Failure, Sepsis, Hepatic Failure

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-21
    End date: 2012-02-24

Blinded BI 201335 (Hcv Protease Inhibitor)
    End date: 2012-02-24

Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2011-11-21
    End date: 2012-02-24

Copegus
    Dosage: discontinued
    End date: 2012-02-24

Blinded BI 201335 (Hcv Protease Inhibitor)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-21
    End date: 2012-02-13

Possible Copegus side effects in 65 year old

Reported by a physician from Germany on 2012-04-04

Patient: 65 year old , weighing 108.0 kg (237.6 pounds)

Reactions: Cerebrovascular Accident, Hemianopia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Copegus
    Dosage: po
    Indication: Hepatitis C
    Start date: 2011-03-29

Victrelis
    Dosage: ;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-14

Other drugs received by patient: Peginterferon Alfa-2A

Possible Copegus side effects in female

Reported by a individual with unspecified qualification from United States on 2012-04-04

Patient: female, weighing 84.5 kg (185.9 pounds)

Reactions: Pneumonia, B-Cell Lymphoma Stage IV, Pulmonary Vasculitis, Pancytopenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Start date: 2011-04-20
    End date: 2011-06-29

Copegus
    Start date: 2011-07-05

Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-04-20

RO 5466731 (Hcv Ns5b Inhibitor)
    Dosage: date of dicontinuation: 05/jul/2011
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-07-05

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-04-27

Copegus
    Start date: 2011-07-05
    End date: 2011-07-05

Peginterferon Alfa-2A
    Start date: 2011-06-29
    End date: 2011-06-29

Peginterferon Alfa-2A
    Start date: 2011-06-29

Copegus
    Administration route: Oral
    Start date: 2011-04-27
    End date: 2011-05-10

Copegus
    Administration route: Oral
    Start date: 2011-05-10
    End date: 2011-07-05

Other drugs received by patient: Lithium Carbonate; RED Cells Pack; Rabeprazole Sodium; Zolpidem; Lasix; Diphenhydramine HCL; Acetaminophen; Protonix; Promethazine; Alprazolam; Spironolactone; Lortab; Lasix; Epoetin Alfa

Possible Copegus side effects in 75 year old female

Reported by a physician from Japan on 2012-04-03

Patient: 75 year old female

Reactions: Superficial Siderosis of Central Nervous System

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2007-07-02
    End date: 2008-02-01

Pegasys
    Indication: Hepatitis C
    Start date: 2007-07-02
    End date: 2008-02-01

Possible Copegus side effects in female

Reported by a individual with unspecified qualification from United States on 2012-04-02

Patient: female, weighing 79.1 kg (174.0 pounds)

Reactions: Pneumonia, B-Cell Lymphoma Stage IV, Pulmonary Vasculitis, Pancytopenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Start date: 2011-04-20
    End date: 2011-06-29

Copegus
    Administration route: Oral
    Start date: 2011-04-27
    End date: 2011-05-10

Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-04-20

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-04-27

Copegus
    Administration route: Oral
    Start date: 2011-05-10
    End date: 2011-07-05

Copegus
    Start date: 2011-07-05
    End date: 2011-07-05

Copegus
    Start date: 2011-07-05

Peginterferon Alfa-2A
    Start date: 2011-06-29

Peginterferon Alfa-2A
    Start date: 2011-06-29
    End date: 2011-06-29

RO 5466731 (Hcv Ns5b Inhibitor)
    Dosage: date of dicontinuation: 05/jul/2011
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-07-05

Other drugs received by patient: Lithium Carbonate; Alprazolam; Epoetin Alfa; Diphenhydramine HCL; Rabeprazole Sodium; Lasix; Acetaminophen; Protonix; Promethazine; Spironolactone; Lasix; Lortab; Zolpidem; RED Cells Pack

Possible Copegus side effects in female

Reported by a individual with unspecified qualification from United States on 2012-03-23

Patient: female, weighing 90.5 kg (199.1 pounds)

Reactions: B-Cell Lymphoma Stage IV, Pneumonia, Pulmonary Vasculitis, Pancytopenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    Start date: 2011-04-27
    End date: 2011-05-10

Copegus
    Administration route: Oral
    Start date: 2011-05-10
    End date: 2011-07-05

Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-04-20

RO 5466731 (Hcv Ns5b Inhibitor)
    Dosage: date of dicontinuation: 05/jul/2011
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-07-05

Peginterferon Alfa-2A
    Start date: 2011-04-20
    End date: 2011-06-29

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-04-27

Other drugs received by patient: Lasix; Promethazine; Rabeprazole Sodium; Alprazolam; Epoetin Alfa; Diphenhydramine HCL; Esomeprazole Sodium; Zolpidem; RED Cells Pack; Acetaminophen; Protonix; Lortab; Spironolactone; Lasix; Lortab; Lithium Carbonate

Possible Copegus side effects in female

Reported by a individual with unspecified qualification from United States on 2012-03-21

Patient: female, weighing 90.5 kg (199.1 pounds)

Reactions: B-Cell Lymphoma Stage IV, Pneumonia, Pulmonary Vasculitis, Pancytopenia

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Start date: 2011-04-20
    End date: 2011-06-29

Blinded RO 5466731 (Hcv Ns5b Inhibitor)
    Dosage: date of dicontinuation: 05/jul/2011
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-07-05

Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-04-20

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-04-27

Copegus
    Administration route: Oral
    Start date: 2011-05-10
    End date: 2011-07-05

Copegus
    Administration route: Oral
    Start date: 2011-04-27
    End date: 2011-05-10

Other drugs received by patient: Protonix; Lortab; Zolpidem; Epoetin Alfa; RED Cells Pack; Rabeprazole Sodium; Acetaminophen; Lortab; Lasix; Esomeprazole; Lasix; Promethazine; Lithium Carbonate; Alprazolam; Spironolactone; Diphenhydramine HCL

Possible Copegus side effects in male

Reported by a physician from United States on 2012-03-14

Patient: male, weighing 58.1 kg (127.8 pounds)

Reactions: Pancreatitis Acute, White Blood Cell Count Decreased, Tooth Abscess, Urinary Tract Infection, Hypophosphataemia, Surgery, Impaired Healing, Vitamin D Decreased, Dental Care, Hypocalcaemia, Diabetic Ketoacidosis, Thrombocytopenia, Type 1 Diabetes Mellitus

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2009-04-01
    End date: 2009-10-05

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2009-04-01
    End date: 2009-10-05

Other drugs received by patient: Pristiq

Possible Copegus side effects in female

Reported by a physician from Canada on 2012-03-13

Patient: female, weighing 78.5 kg (172.7 pounds)

Reactions: Renal Failure, Sepsis, Hepatic Failure

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2011-11-21
    End date: 2012-02-24

Blinded BI 201335 (Hcv Protease Inhibitor)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-21
    End date: 2012-02-13

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-21
    End date: 2012-02-24

Copegus
    Dosage: discontinued
    End date: 2012-02-24

Blinded BI 201335 (Hcv Protease Inhibitor)
    End date: 2012-02-24

Possible Copegus side effects in female

Reported by a physician from Tunisia on 2012-03-09

Patient: female, weighing 63.0 kg (138.6 pounds)

Reactions: Pleural Effusion, Diabetic Retinopathy

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2009-08-19
    End date: 2010-01-27

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2009-08-19
    End date: 2010-01-27

Possible Copegus side effects in male

Reported by a individual with unspecified qualification from United States on 2012-03-07

Patient: male, weighing 69.0 kg (151.8 pounds)

Reactions: Blood Bilirubin Increased, Rash, Chronic Hepatic Failure, Thrombocytopenia

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
BI 201335 (Hcv Protease Inhibitor)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-30
    End date: 2011-12-16

Peginterferon Alfa-2A
    Dosage: last dose prior to sae: 14/dec/2011
    Indication: Hepatitis C
    Start date: 2011-11-30
    End date: 2011-12-16

Copegus
    Dosage: last dose prior to sae: 14/dec/2011
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-30
    End date: 2011-12-16

Other drugs received by patient: Avil; Spironolactone; Propranolol; Lactulose; Calcium; Lasix; Enalapril Maleate; Loperamide HCL

Possible Copegus side effects in male

Reported by a physician from United States on 2012-02-17

Patient: male, weighing 69.0 kg (151.8 pounds)

Reactions: Blood Bilirubin Increased, Thrombocytopenia, Chronic Hepatic Failure

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Copegus
    Dosage: last dose prior to sae: 14/dec/2011
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-30
    End date: 2011-12-16

Peginterferon Alfa-2A
    Dosage: last dose prior to sae: 14/dec/2011
    Indication: Hepatitis C
    Start date: 2011-11-30
    End date: 2011-12-16

BI 201335 (Hcv Protease Inhibitor)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-30
    End date: 2011-12-16

Other drugs received by patient: Propranolol; Enalapril; Spironolactone; Calcium; Lasix; Lactulose

Possible Copegus side effects in male

Reported by a physician from Germany on 2012-02-16

Patient: male, weighing 72.0 kg (158.4 pounds)

Reactions: Depression, Schizophreniform Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Copegus
    Indication: Hepatitis C
    Start date: 2010-07-30
    End date: 2010-10-18

Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2010-07-30
    End date: 2010-10-15

Other drugs received by patient: Paracetamol

Possible Copegus side effects in male

Reported by a individual with unspecified qualification from United States on 2012-02-08

Patient: male, weighing 69.0 kg (151.8 pounds)

Reactions: Blood Bilirubin Increased, Thrombocytopenia, Chronic Hepatic Failure

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Dosage: last dose prior to sae: 14/dec/2011
    Indication: Hepatitis C
    Start date: 2011-11-30
    End date: 2011-12-16

BI 201335 (Hcv Protease Inhibitor)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-30
    End date: 2011-12-16

Copegus
    Dosage: last dose prior to sae: 14/dec/2011
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-30
    End date: 2011-12-16

Other drugs received by patient: Calcium; Lactulose; Propranolol; Lasix; Spironolactone; Enalapril Maleate